
GL Stock Forecast & Price Target
GL Analyst Ratings
Bulls say
Globe Life Inc. is forecasting strong growth in its premium collections, with life insurance premiums expected to increase by 4.0%-5% and supplemental health insurance premiums projected to rise between 9%-16% in the coming year. The company has ramped up its marketing efforts, anticipating a 10% increase in leads generated for its exclusive agencies, which aligns with the upward trajectory of net health sales across its subsidiaries. Additionally, favorable mortality experience contributed to significant remeasurement gains, highlighting the company's robust financial health and solidifying management's confidence in achieving their revised EPS estimates of $14.50 for 2025 and $15.05 for 2026.
Bears say
Globe Life Inc. is projecting a modest operating earnings per share growth of only 3% at the midpoint for 2026, significantly impacted by assumption updates in 2025 and declining remeasurement gains in the Life segment, which are expected to drop from $192 million to between $50-$100 million. Additionally, the potential margin pressures from increasing health utilization, along with risks associated with ongoing EEOC reviews and challenges in salesforce recruiting, raise concerns regarding the company's future revenue growth and overall financial stability. Furthermore, the anticipated underwriting margins suggest fundamental profitability strains, particularly in the Health segment, which may not sufficiently support both earnings expectations and investor confidence in the long term.
This aggregate rating is based on analysts' research of Globe Life Inc and is not a guaranteed prediction by Public.com or investment advice.
GL Analyst Forecast & Price Prediction
Start investing in GL
Order type
Buy in
Order amount
Est. shares
0 shares